Two reports [1,2] from The University of Texas MD Anderson Cancer Center (MDACC), Houston, suggested that angiotensin-converting enzyme (ACE) inhibitors and beta-blockers should be given long term to ...
New Orleans, LA, Nov. 7, 2004 -- Many heart disease patients who are already receiving state-of-the-art therapy do not benefit from additional treatment with angiotensin converting enzyme (ACE) ...
The first study of its kind reports that patients should keep taking well-known heart medications. Patients with heart conditions that require angiotensin-converting enzyme (ACE) inhibitors and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback